Expand TARA Menu
TARA MENU

TARA Stock Posts


Unusual Option Volume

TARA Protara Therapeutics5.10-0.20 (-3.8%)

Protara Therapeutics trades 5,125 contracts. The company has the following event: American Urological Association (AUA) 2026 Annual Meeting on May 15, 2026. News: Protara Therapeutics Announces Positive Updated 12-Month Data Demonstrating Durable Responses in the Fully Enrolled BCG-Nave Cohort of the Ongoing Phase 2 ADVANCED-2 Trial of TARA-002 in NMIBC
View Details...
Unusual Option Volume

TARA Protara Therapeutics5.23+0.09 (+1.8%)

Protara Therapeutics trades 2,120 contracts. The highest volume is in the 15-May-26 5 calls.
View Details...
TARA #ProtaraTherapeutics stock declines -9.8% in premarket,

Premarket Decliner

TARA Protara Therapeutics7.43+0.59+8.6%

Premarket:6.70-0.73 (-9.8%)

TARA-002 Demonstrates 68% Complete Response Rate at Six Months in BCG-Unresponsive Non-Muscle Invasive Bladder Cancer

Globe NewswireMon, 23-Feb 5:05 PM
TARA #ProtaraTherapeutics stock declines -17.9% in after hours trading. See the latest news.

After Hours Decliner

TARA Protara Therapeutics7.43+0.59+8.6%

After Hours:6.10-1.33 (-17.9%)

TARA-002 Demonstrates 68% Complete Response Rate at Six Months in BCG-Unresponsive Non-Muscle Invasive Bladder Cancer

Globe NewswireMon, 23-Feb 5:05 PM
TARA #ProtaraTherapeutics stock declines -16.0% in premarket,

Premarket Decliner

TARA Protara Therapeutics6.87+0.07+1.0%

Premarket:5.77-1.10 (-16.0%)

Protara Announces Pricing of $75 Million Public Offering

Globe NewswireThu, 4-Dec 10:03 PM
TARA #ProtaraTherapeutics stock declines -3.7% in after hours trading. See the latest news.

After Hours Decliner

TARA Protara Therapeutics6.75+1.18+21.2%

After Hours:6.50-0.25 (-3.7%)

Protara Therapeutics to Host Conference Call and Webcast to Review New Interim Data from Phase 2 STARBORN-1 Trial of TARA-002 in Pediatric Patients with Lymphatic Malformations on Wednesday, November 19, 2025

Globe NewswireTue, 18-Nov 4:30 PM
Load Earlier Posts
Market Data Delayed 15 Minutes